000 | 00408nam a2200133Ia 4500 | ||
---|---|---|---|
999 |
_c146331 _d146331 |
||
020 | _a9781848440111 | ||
020 | _a9781847205995 | ||
020 |
_a1848440111 _a1847205992 |
||
040 | _cCUS | ||
082 |
_a346.0486 _bHAR/C |
||
100 | _aHaracoglou, Irina | ||
245 | 0 |
_aCompetition law and patents: a follow-on innovation perspective in the biopharmaceutical industry/ _cIrina Haracoglou |
|
260 |
_aCheltenham, UK: _bEdward Elgar, _c2008. |
||
300 | _a251 p. | ||
505 | _aBiopharmaceutical R & D : the increased importance of cumulative innovation and related concerns The patent system as a system of balancing The patent system and some potential safety nets The right to health as an interpretive principle of patent law Unilateral conduct, IPRs and competition law: a systems' interaction The duty to deal under Art. 82 EC The duty to deal as applied to address technology access problems in the biopharmaceutical industry | ||
650 | _aPatent laws and legislation | ||
650 |
_aPharmaceutical biotechnology _xPatents |
||
650 |
_aPharmaceutical biotechnology _xLaw and legislation |
||
942 | _cWB16 |